New techniques expand potential of Crispr gene editing tool via @FThttps://t.co/2PdQmeVoP1 — The Propell Group (@ThePropellGroup) October 28, 2017
Demand for Apple’s iPhone X exceeds supply via @FThttps://t.co/VyJPL3iJLr — The Propell Group (@ThePropellGroup) October 28, 2017
CVS Health holds deal talks with Aetna via @FThttps://t.co/boYrZHTQrC — The Propell Group (@ThePropellGroup) October 27, 2017
Artificial intelligence: the key to developing effective drugs quickly https://t.co/WT53VCG3Sx — The Propell Group (@ThePropellGroup) October 26, 2017
Apple and Cochlear partner on new hearing implant technology… https://t.co/WpPQxxhgPN — The Propell Group (@ThePropellGroup) October 26, 2017
Amazon Is About To Disrupt The Drug Industry, But Not The Way Most Think https://t.co/Gr1lnas8R0 — The Propell Group (@ThePropellGroup) October 25, 2017
Alzheimer’s immunotherapy boosted by AbbVie deal via @FThttps://t.co/jWiiRKf3qS — The Propell Group (@ThePropellGroup) October 24, 2017
Big Tech vs Big Pharma: the battle over US patent protection https://t.co/wk7nZ1F7EG — The Propell Group (@ThePropellGroup) October 24, 2017
Very relevant takeaways for HealthTech https://t.co/TpwJOUxjYY — The Propell Group (@ThePropellGroup) October 24, 2017
VC funding rising in Singapore https://t.co/BKnqsgBtJE — The Propell Group (@ThePropellGroup) October 23, 2017